MediciNova (NASDAQ:MNOV) Price Target Lowered to $5.00 at B. Riley
MediciNova (NASDAQ:MNOV – Free Report) had its price target reduced by B. Riley from $6.00 to $5.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. Wall Street Zen started coverage […]
MediciNova (NASDAQ:MNOV – Free Report) had its price target reduced by B. Riley from $6.00 to $5.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. Wall Street Zen started coverage […]
